Disclosures for "Subclinical Seizures Contributing to Behavioral Symptoms in Bainbridge-Ropers Syndrome (ASXL3 Mutation) : Improvement with Levetiracetam and Associated Metabolic Findings "
-
Dr. Wang has nothing to disclose.
-
Dr. Waseem has nothing to disclose.
-
Dr. Lembeck has nothing to disclose.
-
Dr. Elamin has nothing to disclose.
-
The institution of Dr. Izadyar has received research support from Xenon Pharmaceuticals. An immediate family member of Dr. Izadyar has received publishing royalties from a publication relating to health care.